![Gene Mack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gene Mack
Amministratore Delegato presso
GAIN THERAPEUTICS, INC.
Patrimonio netto: 24 192 $ in data 31/07/2026
Profilo
Gene C.
Mack is President, Chief Executive Officer & Director at Gain Therapeutics, Inc. starting in 2025.
Former positions include Executive Director at Mizuho Securities USA LLC (2011), Senior Director-Finance & Investor Relations at Edge Therapeutics, Inc. (2013–2015), Managing Director at Brean Capital LLC (2012–2014), Chief Financial Officer & Treasurer at SELLAS Life Sciences Group, Inc. (2018), Chief Financial Officer & Senior Vice President at Ascendia Pharmaceuticals, Inc. (2015–2017), Chief Financial Officer at ImCyse SA (2021–2023), Research Analyst at Soleil Securities Corp.
(2009–2011), Analyst at HSBC Securities (USA), Inc. (2007), Analyst at Ryan, Beck & Co., Inc. (2004), Research Analyst at FM Partners Holdings LLC (2008–2009), and Chief Financial Officer at OncoC4, Inc. Education includes undergraduate and MBAistration degrees from Fordham University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/04/2026 | 14.400 ( 0,03% ) | 24 192 $ | 31/07/2026 |
Posizioni attive di Gene Mack
| Società | Posizione | Inizio |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Amministratore Delegato | 25/06/2024 |
Precedenti posizioni note di Gene Mack
| Società | Posizione | Fine |
|---|---|---|
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Direttore Finanziario/CFO | 01/10/2023 |
| SELLAS LIFE SCIENCES GROUP, INC. | Direttore Finanziario/CFO | 17/12/2018 |
Ascendia Pharmaceuticals, Inc.
 Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract formulation development and manufacturing organization | Direttore Finanziario/CFO | 01/01/2017 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Contatto Relazioni con gli Investitori | 01/01/2015 |
Brean Capital LLC
 Brean Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2014 |
Formazione di Gene Mack
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Ryan, Beck & Co., Inc.
 Ryan, Beck & Co., Inc. Investment Banks/BrokersFinance Provides brokerage and investment banking services | Finance |
Soleil Securities Corp.
 Soleil Securities Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Mizuho Securities USA LLC
 Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
HSBC Securities (USA), Inc.
 HSBC Securities (USA), Inc. Regional BanksFinance Provides banking and financial services | Finance |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Gruntal & Co. LLC
 Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Government |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brean Capital LLC
Brean Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
SELLAS Life Sciences Group, Inc.
 SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Ascendia Pharmaceuticals, Inc.
Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract formulation development and manufacturing organization | Health Technology |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Oncoc4, Inc.
 Oncoc4, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines for cancer | Health Technology |
